Seeking Alpha

  InterMune, Inc. - NASDAQ

11/24/2014, 11:19 AM ET
  • Barry Bazzell | Send Message 3 Mar 2011

    Biotech firm ITMN up over 6% after approval of lung disease drug
      ITMN vs. ETF Alternatives
      Company Description
      InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States